Cardionomic, Inc.

Cardionomic, Inc. is a healthcare technology company focused on developing innovative solutions for cardiac monitoring and treatment, enhancing patient care through advanced medical devices and analytics. Founded in 2011 and headquartered in New Brighton, US, Cardionomic, Inc. specializes in cardiac monitoring solutions.

It successfully completed a Series A funding round in April 2018, raising USD 9. 00 mn led by Ascension Ventures. The company has executed 3 deals since its inception. Cardionomic, Inc.

provides advanced cardiac monitoring devices and analytics, designed to improve the quality of patient care. Their offerings include wearable devices that enable real-time tracking of heart health metrics, tailored to meet the needs of healthcare providers and patients. The company's solutions are marketed to healthcare institutions across North America, Europe, and parts of Asia, ensuring a global reach in cardiac health management. Cardionomic, Inc.

generates revenue primarily through the sale of its medical devices and related services, including subscription-based access to its analytics platform. The pricing structure is adaptable, catering to various healthcare providers, from small practices to large hospitals. Key offerings include comprehensive monitoring solutions that integrate with existing healthcare systems, enhancing patient monitoring and data analysis capabilities. Looking ahead, Cardionomic, Inc.

plans to expand its product line with the introduction of new cardiac monitoring devices set to launch in late 2023. The company aims to enter additional markets in Europe and Asia by 2024, leveraging the recent funding of USD 9. 00 mn from its Series A round to support research and development efforts. This investment will enhance their product offerings and facilitate market penetration strategies.